ABVC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ABVC Biopharma Inc is not a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The stock shows significant financial underperformance, no positive trading signals, and lacks positive catalysts or strong technical indicators to suggest a favorable entry point.
The MACD is slightly positive but contracting, RSI is neutral at 37.081, and moving averages are converging, indicating no strong trend. The stock is trading below key pivot levels, with support at 1.123 and resistance at 1.386. Overall, the technical indicators do not suggest a strong buy signal.
NULL. No recent news, no significant insider or hedge fund activity, and no recent congress trading data.
The stock has declined significantly in both pre-market (-4.58%) and regular market (-6.11%). Financial performance has deteriorated drastically, with revenue, net income, EPS, and gross margin all showing severe YoY declines in Q4 2025.
In Q4 2025, the company reported a 100% drop in revenue, a net income decline of -1653.81% YoY, an EPS drop of -800%, and a gross margin decline of -100%. These metrics indicate severe financial distress.
No analyst ratings or price target changes are available for this stock.
